Found: 31
Select item for more details and to access through your institution.
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 2021, doi. 10.1007/s00277-024-05620-3
- By:
- Publication type:
- Article
Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 6, p. 675, doi. 10.1093/jjco/hyae020
- By:
- Publication type:
- Article
Protocol digest of a randomized controlled Phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced oesophageal squamous cell carcinoma with no pathological complete response after neoadjuvant chemotherapy followed by curative esophagectomy: Japan Clinical Oncology Group study JCOG2206 (SUNRISE Trial)
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 2, p. 212, doi. 10.1093/jjco/hyad150
- By:
- Publication type:
- Article
A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 1, p. 103, doi. 10.1093/jjco/hyad137
- By:
- Publication type:
- Article
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE)
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11503-z
- By:
- Publication type:
- Article
203. SURVIVAL IMPACT OF THORACIC DUCT RESECTION IN PATHOLOGICAL RESPONDERS AFTER TRIPLET CHEMOTHERAPY: EXPLORATORY ANALYSIS FROM MULTICENTER PHASE III TRIAL JCOG1109.
- Published in:
- Diseases of the Esophagus, 2023, v. 36, p. 1, doi. 10.1093/dote/doad052.064
- By:
- Publication type:
- Article
A multicenter randomized controlled trial of esophagectomy with or without prophylactic supraclavicular node dissection: a phase 3 trial (JCOG2013, MODERN3).
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 9, p. 858, doi. 10.1093/jjco/hyad071
- By:
- Publication type:
- Article
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant‐ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 590, doi. 10.1002/hon.3103
- By:
- Publication type:
- Article
Clinical trial design and analysis for comparing three treatments with intra-individual right- and left-hand data.
- Published in:
- Clinical Trials, 2023, v. 20, n. 3, p. 203, doi. 10.1177/17407745221150281
- By:
- Publication type:
- Article
Randomized phase III study of daratumumab versus bortezomib plus daratumumab as maintenance therapy after D-MPB for transplant-ineligible patients with untreated multiple myeloma (JCOG1911, B-DASH study).
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 4, p. 349, doi. 10.1093/jjco/hyac198
- By:
- Publication type:
- Article
Evaluation of breast cosmetic changes with a computer-software; the breast cancer conservative treatment cosmetic results (BCCT. core) in hypofractionated whole breast irradiation after breast-conserving surgery-supplementary analysis of multicenter single-arm confirmatory trial: JCOG0906
- Published in:
- Breast Cancer (13406868), 2022, v. 29, n. 6, p. 1042, doi. 10.1007/s12282-022-01384-8
- By:
- Publication type:
- Article
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
- Published in:
- Cancer Science, 2022, v. 113, n. 9, p. 3267, doi. 10.1111/cas.15484
- By:
- Publication type:
- Article
randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 9, p. 1021, doi. 10.1093/jjco/hyac071
- By:
- Publication type:
- Article
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502.
- Published in:
- Journal of Gastroenterology, 2022, v. 57, n. 7, p. 455, doi. 10.1007/s00535-022-01870-y
- By:
- Publication type:
- Article
Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 6, p. 583, doi. 10.1093/jjco/hyac039
- By:
- Publication type:
- Article
Long-term survival of patients with T1bN0M0 esophageal cancer after thoracoscopic esophagectomy using data from JCOG0502: a prospective multicenter trial.
- Published in:
- Surgical Endoscopy & Other Interventional Techniques, 2022, v. 36, n. 6, p. 4275, doi. 10.1007/s00464-021-08768-5
- By:
- Publication type:
- Article
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part).
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 5, p. 4497, doi. 10.1007/s00520-022-06874-1
- By:
- Publication type:
- Article
P-126: The prognostic impact of the UK Myeloma Research Alliance Risk Profile in untreated patients with multiple myeloma who received melphalan, prednisolone, and bortezomib: an ad hoc analysis of JCOG1105.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S103, doi. 10.1016/S2152-2650(21)02253-9
- By:
- Publication type:
- Article
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212.
- Published in:
- Clinical & Experimental Metastasis, 2021, v. 38, n. 5, p. 459, doi. 10.1007/s10585-021-10117-8
- By:
- Publication type:
- Article
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
- Published in:
- Acta Neuropathologica, 2021, v. 142, n. 2, p. 323, doi. 10.1007/s00401-021-02337-9
- By:
- Publication type:
- Article
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1059, doi. 10.1093/jjco/hyab066
- By:
- Publication type:
- Article
Prognostic Value of Epithelial Cell Adhesion Molecules in T1‐2N0M0 Glottic Cancer.
- Published in:
- Laryngoscope, 2021, v. 131, n. 7, p. 1522, doi. 10.1002/lary.29348
- By:
- Publication type:
- Article
Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 6, p. 865, doi. 10.1093/jjco/hyab024
- By:
- Publication type:
- Article
Predicting study duration in clinical trials with a time-to-event endpoint.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trial.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 1, p. 214, doi. 10.1007/s10120-020-01102-3
- By:
- Publication type:
- Article
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40478-020-01078-2
- By:
- Publication type:
- Article
Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC).
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 11, p. 1321, doi. 10.1093/jjco/hyaa113
- By:
- Publication type:
- Article
Mortality from extrathymic malignancy after thymic tumour resections: incidences and risk factors.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2019, v. 29, n. 5, p. 729, doi. 10.1093/icvts/ivz177
- By:
- Publication type:
- Article
Possibility of a risk‐adapted treatment strategy for untreated aggressive adult T‐cell leukaemia‐lymphoma (ATL) based on the ATL prognostic index: a supplementary analysis of the JCOG9801.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. 440, doi. 10.1111/bjh.15950
- By:
- Publication type:
- Article